Saiju Rohit, Thakur Jaya, Karmacharya Purna Chandra, Shah Dev Narayan
Tilganga Eye Center, Kathmandu, Nepal.
Nepal Med Coll J. 2006 Sep;8(3):171-5.
To determine the clinical profile of retinoblastoma and to provide baseline data for further studies on this subject. Prospective evaluation of 30 consecutive patients with retinoblastoma admitted at the B. P. Koirala Lions Center for Ophthalmic Studies, Kathmandu, Nepal, between October 1998 and July 2000 was carried out. Age, sex, laterality and time from onset of symptoms to diagnosis (lag time) were noted. Ancillary tests were undertaken to rule out metastasis. Male to female ratio was 1.1:1 and the median age of presentation was 3.1 years. Of 30 cases, 23 (76.6%) had unilateral involvement. Leukocoria was the presenting sign in 13 cases (43.3%) and fungating mass in 10 cases (33.3%). In 11 (36.7%), the latency period from onset of symptoms to diagnosis was 6-12 months. In bilateral cases, advanced disease was treated surgically and the fellow eye was treated with cryotherapy, photocoagulation and chemotherapy. Histopathological examination of 21 (70.0%) enucleated/exenterated cases revealed a poorly differentiated type of retinoblastoma. This is the first study of retinoblastoma from Nepal. Early diagnosis of this disease when it is localized to the eye is important to salvage the life of the child. An informational program directed toward the public in general, as well as careful screening of any white pupillary reflex by the pediatrician and/or primary health worker will encourage and support early diagnosis.
确定视网膜母细胞瘤的临床特征,并为该主题的进一步研究提供基线数据。对1998年10月至2000年7月期间在尼泊尔加德满都的B.P.科伊拉腊狮子眼科研究中心收治的30例连续性视网膜母细胞瘤患者进行了前瞻性评估。记录了年龄、性别、病变侧别以及从症状出现到诊断的时间(延迟时间)。进行了辅助检查以排除转移。男女比例为1.1:1,中位就诊年龄为3.1岁。30例患者中,23例(76.6%)为单侧受累。13例(43.3%)以白瞳症为首发体征,10例(33.3%)以真菌样肿物为首发体征。11例(36.7%)从症状出现到诊断的潜伏期为6至12个月。对于双侧病例,对晚期疾病进行手术治疗,对侧眼采用冷冻疗法、光凝疗法和化学疗法治疗。21例(70.0%)眼球摘除/眶内容剜除病例的组织病理学检查显示为低分化型视网膜母细胞瘤。这是来自尼泊尔的第一项关于视网膜母细胞瘤的研究。当这种疾病局限于眼部时早期诊断对于挽救儿童生命很重要。面向公众开展宣传项目,以及儿科医生和/或初级卫生工作者对任何白瞳反射进行仔细筛查,将有助于并支持早期诊断。